Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amos H. E., Lake B. G., Atkinson H. A. Allergic drug reactions: an in vitro model using a mixed function oxidase complex to demonstrate antibodies with specificity for a practolol metabolite. Clin Allergy. 1977 Sep;7(5):423–428. doi: 10.1111/j.1365-2222.1977.tb01473.x. [DOI] [PubMed] [Google Scholar]
- Bodem G., Chidsey C. A. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26–29. doi: 10.1002/cpt197314126. [DOI] [PubMed] [Google Scholar]
- Metzler M. Metabolic activation of carcinogenic diethylstilbestrol in rodents and humans. J Toxicol Environ Health Suppl. 1976;1:21–35. [PubMed] [Google Scholar]
- Nicholls J. T. Adverse effects of practolol. Ann Clin Res. 1976 Aug;8(4):229–231. [PubMed] [Google Scholar]
- Orton T. C., Lowery C., Lindup W. E. Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings). Br J Pharmacol. 1977 Jun;60(2):319P–319P. [PMC free article] [PubMed] [Google Scholar]
- Weir R. C., Porter R. R. The antigen-binding capacity of the peptide chains of horse antibodies. Biochem J. 1966 Jul;100(1):69–72. doi: 10.1042/bj1000069. [DOI] [PMC free article] [PubMed] [Google Scholar]